vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $30.3M, roughly 1.6× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -71.6%, a 58.7% gap on every dollar of revenue. On growth, SYPRIS SOLUTIONS INC posted the faster year-over-year revenue change (-9.5% vs -11.8%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-24.9M). Over the past eight quarters, SYPRIS SOLUTIONS INC's revenue compounded faster (-7.7% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.

MRVI vs SYPR — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.6× larger
MRVI
$49.9M
$30.3M
SYPR
Growing faster (revenue YoY)
SYPR
SYPR
+2.4% gap
SYPR
-9.5%
-11.8%
MRVI
Higher net margin
SYPR
SYPR
58.7% more per $
SYPR
-12.9%
-71.6%
MRVI
More free cash flow
SYPR
SYPR
$23.4M more FCF
SYPR
$-1.5M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
SYPR
SYPR
Annualised
SYPR
-7.7%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
SYPR
SYPR
Revenue
$49.9M
$30.3M
Net Profit
$-35.7M
$-3.9M
Gross Margin
25.8%
4.6%
Operating Margin
-117.9%
-10.9%
Net Margin
-71.6%
-12.9%
Revenue YoY
-11.8%
-9.5%
Net Profit YoY
-37.7%
-2992.6%
EPS (diluted)
$-0.24
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
SYPR
SYPR
Q4 25
$49.9M
$30.3M
Q3 25
$41.6M
$28.7M
Q2 25
$47.4M
$31.4M
Q1 25
$46.9M
$29.5M
Q4 24
$56.6M
$33.4M
Q3 24
$69.0M
$35.7M
Q2 24
$69.4M
$35.5M
Q1 24
$64.2M
$35.6M
Net Profit
MRVI
MRVI
SYPR
SYPR
Q4 25
$-35.7M
$-3.9M
Q3 25
$-25.6M
$517.0K
Q2 25
$-39.6M
$-2.1M
Q1 25
$-29.9M
$-899.0K
Q4 24
$-25.9M
$135.0K
Q3 24
$-97.1M
$390.0K
Q2 24
$-9.8M
$16.0K
Q1 24
$-12.1M
$-2.2M
Gross Margin
MRVI
MRVI
SYPR
SYPR
Q4 25
25.8%
4.6%
Q3 25
13.6%
7.2%
Q2 25
16.4%
8.2%
Q1 25
16.5%
11.4%
Q4 24
34.3%
16.1%
Q3 24
46.7%
16.8%
Q2 24
44.4%
15.9%
Q1 24
40.3%
8.1%
Operating Margin
MRVI
MRVI
SYPR
SYPR
Q4 25
-117.9%
-10.9%
Q3 25
-98.6%
-6.1%
Q2 25
-139.8%
-4.6%
Q1 25
-104.9%
-0.4%
Q4 24
-66.7%
3.9%
Q3 24
-239.9%
4.8%
Q2 24
-19.4%
3.6%
Q1 24
-29.4%
-3.9%
Net Margin
MRVI
MRVI
SYPR
SYPR
Q4 25
-71.6%
-12.9%
Q3 25
-61.4%
1.8%
Q2 25
-83.5%
-6.5%
Q1 25
-63.9%
-3.0%
Q4 24
-45.8%
0.4%
Q3 24
-140.6%
1.1%
Q2 24
-14.1%
0.0%
Q1 24
-18.8%
-6.2%
EPS (diluted)
MRVI
MRVI
SYPR
SYPR
Q4 25
$-0.24
$-0.17
Q3 25
$-0.18
$0.02
Q2 25
$-0.27
$-0.09
Q1 25
$-0.21
$-0.04
Q4 24
$-0.21
$0.00
Q3 24
$-0.68
$0.02
Q2 24
$-0.07
$0.00
Q1 24
$-0.09
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
SYPR
SYPR
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$17.8M
Total Assets
$770.6M
$107.8M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
SYPR
SYPR
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
MRVI
MRVI
SYPR
SYPR
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
SYPR
SYPR
Q4 25
$212.4M
$17.8M
Q3 25
$245.4M
$20.0M
Q2 25
$265.9M
$18.7M
Q1 25
$300.6M
$19.0M
Q4 24
$325.3M
$19.6M
Q3 24
$344.9M
$18.2M
Q2 24
$434.7M
$19.0M
Q1 24
$410.7M
$20.8M
Total Assets
MRVI
MRVI
SYPR
SYPR
Q4 25
$770.6M
$107.8M
Q3 25
$849.2M
$112.5M
Q2 25
$897.0M
$105.8M
Q1 25
$959.8M
$110.2M
Q4 24
$1.0B
$119.4M
Q3 24
$1.3B
$121.6M
Q2 24
$1.4B
$124.2M
Q1 24
$1.4B
$129.0M
Debt / Equity
MRVI
MRVI
SYPR
SYPR
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
SYPR
SYPR
Operating Cash FlowLast quarter
$-22.8M
$-1.1M
Free Cash FlowOCF − Capex
$-24.9M
$-1.5M
FCF MarginFCF / Revenue
-49.9%
-5.0%
Capex IntensityCapex / Revenue
4.2%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$-6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
SYPR
SYPR
Q4 25
$-22.8M
$-1.1M
Q3 25
$-15.2M
$-178.0K
Q2 25
$-10.3M
$1.1M
Q1 25
$-9.4M
$-5.5M
Q4 24
$-14.6M
$2.3M
Q3 24
$13.1M
$-4.8M
Q2 24
$17.4M
$6.2M
Q1 24
$-8.5M
$-1.7M
Free Cash Flow
MRVI
MRVI
SYPR
SYPR
Q4 25
$-24.9M
$-1.5M
Q3 25
$-18.1M
$-390.0K
Q2 25
$-13.1M
$941.0K
Q1 25
$-14.6M
$-5.5M
Q4 24
$-20.5M
$1.9M
Q3 24
$4.5M
$-4.9M
Q2 24
$7.9M
$6.0M
Q1 24
$-14.1M
$-2.0M
FCF Margin
MRVI
MRVI
SYPR
SYPR
Q4 25
-49.9%
-5.0%
Q3 25
-43.4%
-1.4%
Q2 25
-27.7%
3.0%
Q1 25
-31.2%
-18.8%
Q4 24
-36.2%
5.7%
Q3 24
6.6%
-13.8%
Q2 24
11.4%
16.8%
Q1 24
-22.0%
-5.7%
Capex Intensity
MRVI
MRVI
SYPR
SYPR
Q4 25
4.2%
1.3%
Q3 25
7.0%
0.7%
Q2 25
6.1%
0.5%
Q1 25
11.2%
0.0%
Q4 24
10.3%
1.2%
Q3 24
12.4%
0.4%
Q2 24
13.8%
0.5%
Q1 24
8.8%
0.9%
Cash Conversion
MRVI
MRVI
SYPR
SYPR
Q4 25
Q3 25
-0.34×
Q2 25
Q1 25
Q4 24
17.13×
Q3 24
-12.21×
Q2 24
385.25×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

SYPR
SYPR

Sypris Electronics$17.7M59%
Transferred At Point In Time$12.5M41%

Related Comparisons